SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cell Genesys (CEGE) -- Ignore unavailable to you. Want to Upgrade?

To: Timoteo who wrote (770)3/14/2000 11:22:00 AM
From: Sten Frelles  Read Replies (1) | Respond to of 1298
 
CEGE just crossing below 30«. How much downside do you think there is at this point - and how long before a return to the high 40's?
Apparently this stock at first looks seems grossly undervalued, but investors don't seem to share that opinion.
Any idea of what's going on, considering that the last couple of days have been more harsh on CEGE than the rest of the biotechs in general ?



To: Timoteo who wrote (770)3/14/2000 11:55:00 AM
From: Tom Hua  Read Replies (2) | Respond to of 1298
 
Timoteo, ABGX is indeed melting down, I covered yesterday (obvioulsy 1 day too early) from high 300s. The whole sector is correcting, like they say, "healthy pullback".

Regards,

Tom


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News